Trademark
Full logoAbout Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biotech with leading franchises in ophthalmology (Eylea, Eylea HD), immunology and inflammation (Dupixent in partnership with Sanofi), oncology (Libtayo), and most recently rare cancers (Lynozyfic). Founded in 1988 by Dr. Leonard Schleifer and headquartered in Tarrytown, New York, Regeneron is built around its proprietary VelociSuite of antibody discovery technologies (VelocImmune, VelociGene, VelociMouse). Dupixent is one of the best-selling biologics in the world. The company also developed REGEN-COV, an early COVID-19 antibody therapy used widely in 2020-2021.
About the Regeneron Pharmaceuticals logo
The Regeneron Pharmaceuticals (REGN) logo is part of the Tickericons pack — a hand-crafted set of logos for every company in the S&P 500. Each logo is manually redrawn to a consistent grid, weight, and corner radius so REGN sits cleanly next to other tickers in cap tables, dashboards, equity research, and fintech UI.
You get two styles: the trademark (just the symbol, ideal for grids and tight UI) and the full logo (mark plus wordmark, ideal when there's room to breathe). Both ship as scalable SVG, high-resolution PNG, and reusable Figma components.
Regeneron Pharmaceuticals was added to the S&P 500 on May 1, 2013 and is currently classified under the Health Care sector.
Index history
Apr 30, 2013 · Added to the S&P 500
A majority of MetroPCS was acquired by T-Mobile
Other Health Care companies
See all →
abtAbbott LaboratoriesMar 4, 195725,279
abbvAbbVieDec 31, 20124,888
aAgilent TechnologiesJun 5, 20009,480
algnAlign TechnologyJun 19, 20173,257
amgnAmgenJan 2, 199212,557
baxBaxter InternationalSep 30, 197219,590
bdxBecton Dickinson and CoSep 30, 197219,590
techBio-Techne CorporationAug 30, 20211,724
biibBiogenNov 13, 20038,224
bsxBoston Scientific CorporationFeb 24, 199511,408
Get all S&P 500 logos
One-time payment. SVG, PNG, and a Figma library. Free updates as the index changes.